FitLife Brands price target lowered to $17 from $25 at Roth Capital

Roth Capital lowered the firm’s price target on FitLife Brands (FTLF) to $17 from $25 and keeps a Buy rating on the shares after its Q4 results came in below estimates. The decline in earnings was driven by slowdown in some products sold online, high protein costs, and discontinuation of CBD, and while some core products continue to show good growth, others that began slowing in Q3 continued to slow in Q4, the analyst tells investors in a research note.